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Abstract: The history of cardiac pacing therapy must be viewed within the broader framework of electro-diagnosis and 
electro-therapy. Electro-therapy has a simple core concept: the use of an outside source of electricity to stimulate human 
tissue in various ways to produce a beneficial therapeutic effect. This has shown a prolonged, halting development 
through the ages, sometimes being looked upon as mysterious magic produced by complex machines. The field of 
paediatric open heart surgery gave a major impetus to the development of pacemakers since heart block often 
accompanied impeccably performed intra-cardiac repairs of congenital defects. This review deals various of aspects of 
pacemaker functioning, indications, contraindications and complications. 
Keywords: Pacemakers, Codes, Implantable cardioverter defibrillator, Heart block, Conduction system. 
INTRODUCTION 
Cardiac implantable electronic device (CIED) has 
been improving over the past few years and the 
number of patients using this device has continued to 
grow. The first pacemaker implant was introduced in 
1958, which is asynchronous type and functioned for 
3years. First on demand pacemaker (DVI) was 
introduced in 1964. In 1977 first atrial and ventricular 
demand pacing (DDD) came into use. Later on rate 
responsive pacing and resynchronization pacing were 
introduced but the automatic capture detection was 
introduced only in 1998. First human implants were 
done in 1980 by cardiac surgeons under general 
anesthesia. The devices were large and were placed in 
abdomen and required thorocotomy with perioperative 
mortality rate upto 9%. They lasted for 1.5years. Today 
they evolved as small devices placed in pectoral pocket 
under local anesthesia. Their battery lasted for 9years 
with perioperative mortality<1%. 
PARTS OF PACEMAKERS  
A pacemaker is a device that regulates the heart 
beat. They provide electrical stimuli to cause cardiac 
contraction when intrinsic cardiac activity is 
inappropriately slow or absent. It consists of 
1. Generator 
A Generator is a device containing a battery that 
provides the energy for sending electrical impulses to 
the heart and an electric circuitry that controls 
pacemaker operations, placed subcutaneously or 
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submuscularly, connected to leads. The battery has life 
span of 5-8yrs and is made of lithium-iodide type [1, 2]. 
2. Leads 
Leads are electronic wires that Deliver electrical 
impulses from the pulse generator to the heart and 
sense cardiac depolarization. 
3. Electrode 
Consists of Cathode (negative electrode), an 
electrode that is in contact with the heart tissue and 
Anode (positive electrode), an electrode that receives 
the electrical impulse after depolarization of cardiac 
tissue 
DEFINITIONS  
Pacing Rate 
Frequency at which heart is stimulated in the 
absence of sensed cardiac activity. Mostly pacing pulse 
width is 0.5-1.5msec width, voltage around 2.5-5volts. 
Pacing Threshold 
Minimum energy required to capture the atria or 
ventricle. It is determined by intrinsic excitability of 
myocardium, duration of electrical pulse. Factors 
influencing are - Increase: propranolol, verapamil, 
antiarrhythmics, potassium, insulin, hypothyroidism 
&MI. Decrease: exercise, hyperthyroidism, hypoxia, 
glucocorticoids, sympathetic drugs. 
Sensing 
Sensing is the ability of the pacemaker to “see” 
when a natural (intrinsic) depolarization is occurring. 
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Pacemakers sense cardiac depolarization by 
measuring changes in electrical potential of myocardial 
cells between the anode and cathode. 
Accurate Sensing 
Accurate sensing enables the pacemaker to 
determine whether or not the heart has created a beat 
on its own. Ensures that undersensing and oversensing 
will not occur. Provides proper timing of the pacing 
pulse. 
Undersensing 
Pacemaker fails to sense P or R waves that should 
have been sensed 
Oversensing 
Pacemaker mistakes extra-cardiac activity for 
intrinsic cardiac events and generate an impulse. 
A-V Interval 
Maximum time interval between atrial and 
ventricular events. Starts with paced or spontaneous 
atrial beat and termination with initiation of paced or 
spontaneous ventricular event, takes 150-200msec 
usually. 
Automatic interval 
Time in milliseconds between successive 
pacemaker impulses 
Escape Interval 
Time the generator takes to emit an impulse in the 
absence of R wave. 
R-Wave Sensitivity 
No: of milivolts required to activate the sensing 
circuit and inhibit the pacing circuit. 
Inhibited Pacemaker 
Has a sensing circuit that detects R wave, 
compares it with standard and finally inactivates the 
pacing circuit if R-waves meet standard (ie., magnitude 
>1.5mv, slew rate>0.5v/sec, frequency >70bpm) 
Rate Adaptive Pacemaker 
Varies its automatic interval with the metabolic state 
or movement of the patient, it paces at baseline and 
increases the rate if patient exercises. 
Blanking Period 
Period after a paced or sensed event during which 
pacemaker does not respond to any ECG event. 
Pacemakers can employ unipolar or bipolar leads. 
Over the past 15yrs bipolar leads has been in use. 
Unipolar Pacemaker 
It has only one electrode that contacts the heart at 
its tip, called the cathode. The anode is the pulse 
generator. Electromagnetic interference occurs more 
often in unipolar leads. 
Bipolar Pacemaker 
In this both anode and cathode are present on the 
heart. Provides more contact with the endocardium, 
needs lower current to pace. Less chance for cautery 
interference. 
Table 1: Pacemaker Codes and Nomenculature 
I II III IV V 
Chamber Paced Chamber Sensed Response to Pacing Rate Modulation, 
Programmability 
Anti-Tachycardia 
Features 
A – Atrium A – Atrium T – Triggered P – Simple P – Pacing 
V – Ventricle V – Ventricle I - Inhibited M–Multi-programmable S – Simple  
D – Dual D – Dual D – Dual R – Rate adaptive D – Dual 
O - None O - None O - None C-Communicating  
   O - None  
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PACEMAKER CODES 
Most Pacemakers Perform Four Functions: 
• Stimulate cardiac depolarization 
• Sense intrinsic cardiac function 
• Respond to increased metabolic demand by 
providing rate responsive pacing 
• Provide diagnostic information stored by the 
pacemaker 
The North American Society for Pacing and 
Electrophysiology (NASPE) and the British Pacing and 
Electrophysiology group (BSEP) has adapted a generic 
code which has been universally adapted to avoid 
confusion and improve communication [3]. 
TYPES OF PACEMAKERS 
• Asynchronous / Fixed rate: does not synchronise 
with intrinsic heart rate. Can be used safely in 
patients with no inrtrinsic ventricular activity. If 
patient has ventricular activity it competes with 
patients own conduction system causing 
ventricular tachycardia (R –on- T phenomenon) 
eg: VOO, AOO, DOO. 
• Synchronous / Demand: It contains two circuits, 
one forms impulse, one acts as a sensor. When 
activated by an R wave, sensing circuit either 
triggers or inhibits the pacing circuit, called 
“Triggered” or “Inhibited” pacers. This is most 
frequently used pacer as it eliminates 
competition.eg: DDI, VVI/VVT, AAI/AAT. 
• Single chamber: The pacing lead is implanted in 
the atrium or ventricle, depending on the 
chamber to be paced and sensed. It is 
asynchronous pacing. Single ventricular lead 
does not provide AV synchrony and single atrial 
lead does not provide ventricular backup if A-to-
V conduction is lost. 
• Dual chamber: This has two leads palced one in 
ventricle and one in atria. It is physiological 
pacing mode as ventricular systole is preceeded 
by atrial contraction and the atrial rate is the 
same as the ventricular rate. It provides atrial 
kick, optimizes left ventricular filling, AV 
synchrony and eventually improves cardiac 
outut. It minimizes AV valve regurgitation that 
occurs with other modes. Lower incidence of 
atrial fibrillation, new congestive heart failure, 
lowers risk of systemic embolism, stroke, 
mortality and higher survival rates. 
• Programmable / nonprogrammable: Recently 
pacemakers have inbuilt rate modulation or 
programmability which allows them to increase 
the heart rate in response to increase physical 
activity (body movement, excersise) or 
physiological needs. 
INDICATIONS OF PACEMAKERS 
AOO: sinus node dysfunction like bradycardia with 
normal AV conduction. 
VOO: significant bradycardia with normal sinus 
rhythm, chronic AF. It is a temporary mode. 
AAI: sick sinus syndrome in the absence of AV 
node disease or atrial fibrillation. 
VVI: symptomatic bradycardia caused by sinus 
node dysfunction, AV block, chronic atrial arrhythmias 
{AF}. 
DVI: useful in dual chamber pacing when atrial 
sensing is not required. 
DOO: highly potential for serious ventricular 
arrhythmias. 
DDD: AV conduction disorders with normal or 
abnormal sinus node function. Contraindicated in 
persistant atrial tachyarrhythmias and silent atria. 
Patients with LVH and LV dysfunction who need 
coordination of atrial and ventricular contraction to 
maintain cardiac output. 
VDD: AV block with intact sinus node function 
(particularly in congenital AV block). 
The final recommendations for indications for device 
therapy are expressed in the standard ACC/AHA 
format: 
Class I: Conditions for which there is evidence 
and/or general agreement that a given procedure or 
treatment is beneficial, useful, and effective. 
Class II: Conditions for which there is conflicting 
evidence and/or a divergence of opinion about the 
usefulness/efficacy of a procedure or treatment. 
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Class II a: Weight of evidence/opinion is in favor of 
usefulness/efficacy. 
Class II b: Usefulness/efficacy is less well 
established by evidence/opinion. 
Class III: Conditions for which there is evidence 
and/or general agreement that a procedure/treatment is 
not useful/effective and in some cases may be harmful. 
Indications for Permanent Pacing in Acquired 
Atrioventricular Block in Adults 
Class I 
• Third-degree AV block at any anatomic level 
associated with any one of the following 
conditions: 
• Bradycardia with symptoms presumed to be due 
to AV block.(Level of evidence: C). 
• Arrhythmias and other medical conditions that 
require drugs that result in symptomatic 
bradycardia. (Level of evidence: C). 
• Documented periods of asystole 3.0 seconds or 
any escape rate <40 beats per minute (bpm) in 
awake, symptom-free patients. (Level of 
evidence: B, C). 
• After catheter ablation of the AV junction. (Level 
of evidence: B, C) There are no trials to assess 
outcome without pacing, and pacing is virtually 
always planned in this situation unless the 
operative procedure is AV junction modification. 
• Postoperative AV block that is not expected to 
resolve. (Level of evidence: C). 
• Neuromuscular diseases with AV block such as 
myotonic muscular dystrophy, Kearns-Sayre 
syndrome, Erb’s dystrophy (limb-girdle), and 
peroneal muscular atrophy. (Level of evidence: 
B). 
• Second-degree AV block regardless of type or 
site of block, with associated symptomatic 
bradycardia. (Level of evidence: B). 
Class II a 
• Asymptomatic third-degree AV block at any 
anatomic site with average awake ventricular 
rates of 40 bpm or faster. (Level of evidence: B, 
C) 
• Asymptomatic type II second-degree AV 
block.(Level of evidence: B) 
• Asymptomatic type I second-degree AV block at 
intra- or infra-His levels found incidentally at 
electrophysiological study for other indications. 
(Level of evidence: B) 
• First-degree AV block with symptoms suggestive 
of pacemaker syndrome and documented 
alleviation of symptoms with temporary AV 
pacing. (Level of evidence: B) 
Class II b 
• Marked first-degree AV block (>0.30 second) in 
patients with LV dysfunction and symptoms of 
congestive heart failure in whom a shorter AV 
interval results in hemodynamic improvement, 
presumably by decreasing left atrial filling 
pressure. (Level of evidence: C) 
Class III 
• Asymptomatic first-degree AV block. (Level of 
evidence: B 
• Asymptomatic type I second-degree AV block at 
the supra-His (AV node) level or not known to be 
intra- or infra-Hisian.(Level of evidence: B, C) 
• AV block expected to resolve and unlikely to 
recur (eg, drug toxicity, Lyme disease). (Level of 
evidence: B) 
INDICATIONS FOR PERMANENT PACING AFTER 
THE ACUTE PHASE OF MYOCARDIAL 
INFARCTION 
Class I 
• Persistent second-degree AV block in the His-
Purkinje system with bilateral bundle branch 
block or third-degree AV block within or below 
the His-Purkinje system after AMI. (Level of 
evidence: B) 
• Transient advanced (second- or third-degree) 
infranodal AV block and associated bundle 
branch block. If the site of block is uncertain, an 
electrophysiological study may be 
necessary.(Level of evidence: B) 
• Persistent and symptomatic second- or third-
degree AV block. (Level of evidence: C) 
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Figure 1: Treatment of Sinus node with Pacemakers. 
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Figure 2: Treatment of heartblock with pacemakers. 
Class II a 
None. 
Class II b 
• Persistent second- or third-degree AV block at 
the AV node level. (Level of evidence: B) 
Class III 
• Transient AV block in the absence of 
intraventricular conduction defects. (Level of 
evidence: B) 
• Transient AV block in the presence of isolated 
left anterior fascicular block. (Level of evidence: 
B) 
• Acquired left anterior fascicular block in the 
absence of AV block. (Level of evidence: B) 
• Persistent first-degree AV block in the presence 
of bundle branch block that is old or age 
indeterminate. (Level of evidence: B) 
IMPLANTABLE CARDIOVERTERDEFIBRILATOR 
(ICD’S) 
These are designed to treat cardiac 
tachydysrythmias. They are capable of detecting a 
ventricular arrhythmia and delivering a defibrillator 
shock/cardioversion. They have antitachycardia pacing 
activity and have pacemaker function also(combo 
devices). Present day ICD’s can terminate 98% of 
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ventricular fibrillation episodes. These devices consists 
of electronic circuitry, power source, microprocessor, 
memory, leads and discharges from 1v-750v. 
ICD’s measure each cardiac R-R interval. IT 
reconfirms VT/VF and can differentiate VT from SVT. It 
gives a shock usually at 25 J. it takes 5-20 seconds to 
sense VT/VF and 5-15 sec to charge and 2.5-10 sec 
delay before next shock is administered. Delivers 
totally 5 shocks then pauses. During shock delivery if 
the patient has to be touched (while doing CPR) rubber 
gloves have to be worn for insulation. 
INDICATIONS 
Survivors of cardiac arrest due to VF or 
hemodynamically unstable VT 
Structural heart disease and spontaneous sustained 
VT 
LVEF <35% due to prior MI who are atleast 40dys 
post MI and DCM with EF<35% who are in NYHA class 
II or III 
Non sustained VT due to prior MI, LVEF<40% and 
inducible VF or sustained VT at electrophysiological 
study. 
Unexplained syncope, nonischemic DCM 
Patients with long QT syndrome 
COMPLICATIONS 
Pacemaker 
Early complications include pneumothorax, 
subcutaneous emphysema, myocardial perforation, 
arterial lead placement, brachial plexus injury. Late 
complications include pulse generator erosion, 
thromboembolism, lead defects, battery depletion, 
allergy, twiddler syndrome, failure to capture and 
sensing abnormalities. 
Pacemaker syndrome: symptoms like weakness, 
lethargy, lassitude, syncope, light headedness, cough, 
chest pain, dyspnea and signs like orthostatic 
hypotension, cannon A waves, decreased cardiac 
output, CHF are seen in patients with pacemaker. 
These are due to retrograde atrial activation by non-
synchronous ventricular pacing modes. 
The complication of ICD’sare same as pacemakers 
except that there can be inappropriate or ineffective 
cardioversion/ defibrillation. 
Electromagnetic interference (EMI): Any device that 
emits radiofrequency waves between 0 and 10 Hz 
cause EMI and interfere with pacemaker/ICD function. 
Eg: metal detectors, cell phones, MRI, electrocautery, 
ESWL, electroconvulsive therapy, radiofrequency 
ablation, shivering, fasciculations and large tidal 
volumes. High frequency waves (X rays, alpha waves, 
infrared and ultraviolet waves) are unlikely to interfere 
with CIED. EMI interference can result in- 
Inappropriate inhibition or triggering of a paced 
output 
Asynchronous pacing 
Reprogramming into a backup mode (VOO/VVI) 
With ICD’s inappropriate delivery of defibrillator 
shock occurs. 
These problems have been overcome by modern 
pacemakers because of the availability of bipolar leads, 
filters and circuit shields. 
Table 2: Defibrillation Codes for AICD 
I II III IV 
Shock Chamber Antitachycardia Chamber Tachycardia Detection Antibradycardia Pacing 
A – Atrium A – Atrium E – EKG A – Atrium 
V – Ventricle V – Ventricle H - Hemodynamics V – Ventricle 
D – Dual D – Dual  D – Dual 
O - None O - None  O – None 
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Figure 3: Perioperative management of Pacemakers and AICD. 
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Table 3: Step Wise Approach to the Perioperative Treatment of the Patient with CIED [4]
 
Patients with CIED Focused history and physical examination 
Determine the type of CIED -
pacemaker/ICD 
Identify the CIED, manufacture details 
Chest x-ray, past medical records, cardiology consultation 
Determine whether patient is 
dependent on CIED  
History  
Bradyarrythmiasymptoms 
Atrioventricular node ablation 
No spontaneous ventricular activity 
Preoperative  
evaluation 
Determine CIED function Comprehensive CIED evaluation 
Determine whether pacing pulses are present and create 
paced beats 
EMI unlikely during the procedure  No special precautions are required 
EMI likely, patient has pacemaker Reprogramme to asynchronous mode when indicated 
Suspend rate-adaptive functions 
EMI likely, patient has ICD Suspend antitachyarrythmia functions 
If patient is dependent on pacing alter pacing function as above 
EMI likely, all CIED Use bipolar cautery, ultrasonic scalpel 
Temporary pacing and external cardioversion-defibrillation 
should be available 
Preoperative preparation 
Intraoperative physiologic changes 
likely (eg: bradycardia, ischemia) 
Plan for possible adverse CIED -patient interaction 
Monitoring ECG, SpO2, etc as per ASA standards 
Electrocautery interference Avoid proximity of cautery tool (CT) to pulse 
generator(PG)/leads. 
Short bursts at lowest possible energy should be used. 
Use bipolar cautery, ultrasonic scalpel. 
Radiofrequency catheter ablation. Avoid contact of radiofrequency catheter with PG/leads 
Radiofrequency current path far away from PG/leads 
Discuss these concerns with the operator 
Lithotripsy Do not focus lithotripsy beam near PG 
If R wave triggers lithotripsy, disable atrial pacing 
MRI Generally contraindicated 
If required, consult operating physician, cardiologist, radiologist 
and manufacturer 
Radiation therapy PG/leads must be outside of RT field 
Possible surgical relocation of PG 
Verify PG function during/after RT course 
Intraoperative management 
Electroconvulsive therapy Consult with ordering physician, patient’s cardiologists, CIED 
service / manufacturer 
ICD: magnet disabled Terminate all EMI sources 
Remove magnet to re-enable therapies 
Observe for appropriate therapies 
ICD: programming disabled Programming to re-enable therapies or proceed directly with 
external cardioversion-defibrillation 
Emergency 
defibrillation/cardioversion 
ICD: either of the above Minimize current flow through PG/leads 
External pads and paddles for cardioversion/defibrillation (PP) 
to be placed as far as possible from PG 
PP to be placed perpendicular to major axis PG/leads 
PP placed in anterior-posterior location 
Immediate postoperative period - 
regardless of CIED type 
Use clinically appropriate cardioversion/defibrillation energy 
Monitor cardiac rhythm & rate continuously 
Backup pacing and cardioversion/defibrillation capability 
Postoperative management 
Postoperative interrogation & 
restoration of CIED function 
Interrogation to assess function 
Appropriate settings to be done, ICD : early restoration of anti-
tachyarrythmia function 
Use cardiologist/pacemaker-ICD service if needed 
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CONCLUSION 
The prevention and treatment of life-threatening 
brad arrhythmias have been revolutionized in the last 
half century by electronic pacemakers. The primary 
purpose of a pacemaker is to maintain an adequate 
heart rate, either because the heart's natural 
pacemaker is not fast enough, or there is a block in the 
heart's electrical conduction system. Most of the 
scientists and physicians involved in electro-therapy 
faced significant criticism and sometimes even derision 
by the contemporary scientific community. Yet the 
specialty moved steadily on gaining medical 
respectability and now helps countless patients all over 
the world. 
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